Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR
Open Access
- 22 September 2011
- journal article
- Published by Springer Nature in Molecular Cancer
- Vol. 10 (1) , 116
Abstract
Background: Epidermal growth factor receptor (EGFR) has been reported to downregulate E-cadherin (E-cad); however, whether the downregulation of E-cad has any effect on EGFR expression has not been elucidated. Our previous studies have found an inverse correlation between EGFR and E-cad expression in tissue specimens of squamous cell carcinoma of the head and neck (SCCHN). To understand the biological mechanisms underlying this clinical observation, we knocked down E-cad expression utilizing E-cad siRNA in four SCCHN cell lines. Results: It was observed that downregulation of E-cad upregulated EGFR expression compared with control siRNA-transfected cells after 72 hours. Cellular membrane localization of EGFR was also increased. Consequently, downstream signaling molecules of the EGFR signaling pathway, p-AKT, and p-ERK, were increased at 72 hours after the transfection with E-cad siRNA. Reverse transcriptase-polymerase chain reaction (RT-PCR) showed EGFR mRNA was upregulated by E-cad siRNA as early as 24 hours. In addition, RT-PCR revealed this upregulation was due to the increase of EGFR mRNA stability, but not protein stability. Sulforhodamine B (SRB) assay indicated growth of E-cad knocked down cells was enhanced up to 2-fold more than that of control siRNA-transfected cells at 72-hours post-transfection. The effect of E-cad reduction on cell proliferation was blocked by treating the E-cad siRNA-transfected cells with 1 μM of the EGFR-specific tyrosine kinase inhibitor erlotinib. Conclusion: Our results suggest for the first time that reduction of E-cad results in upregulation of EGFR transcriptionally. It also suggests that loss of E-cad may induce proliferation of SCCHN by activating EGFR and its downstream signaling pathways.Keywords
This publication has 29 references indexed in Scilit:
- Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transitionNature Cell Biology, 2004
- E‐cadherin‐mediated adhesion inhibits ligand‐dependent activation of diverse receptor tyrosine kinasesThe EMBO Journal, 2004
- Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.2002
- HER-2/neu Oncogene Characterization in Head and Neck Squamous Cell CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1995
- Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.1993
- Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.1993
- The EGF Receptor System as a Target for Antitumor TherapyCancer Investigation, 1991
- The epidermal growth factor receptor and the prognosis of bladder cancerCancer, 1990
- BIOLOGY, CYTOGENETICS, AND SENSITIVITY TO IMMUNOLOGICAL EFFECTOR-CELLS OF NEW HEAD AND NECK SQUAMOUS-CELL CARCINOMA LINES1989
- ESTABLISHMENT AND CHARACTERIZATION OF 2 NEW SQUAMOUS-CELL CARCINOMA CELL-LINES DERIVED FROM TUMORS OF THE HEAD AND NECK1988